Trial Profile
The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2020
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ExeBAT
- 03 May 2018 Status changed from recruiting to completed.
- 23 Aug 2016 New trial record